Gianmario Candore

1.2k total citations
18 papers, 515 citations indexed

About

Gianmario Candore is a scholar working on Toxicology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gianmario Candore has authored 18 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Toxicology, 6 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gianmario Candore's work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Drug-Induced Adverse Reactions (6 papers) and Pharmaceutical studies and practices (5 papers). Gianmario Candore is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (10 papers), Drug-Induced Adverse Reactions (6 papers) and Pharmaceutical studies and practices (5 papers). Gianmario Candore collaborates with scholars based in Netherlands, United Kingdom and Germany. Gianmario Candore's co-authors include Jim Slattery, A Wisniewski, Suzie Seabroke, Peter Arlett, Kristina Juhlin, Bharat Thakrar, Katrin Manlik, Xavier Kurz, G. Niklas Norén and Jean‐Michel Dogné and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and Drug Safety.

In The Last Decade

Gianmario Candore

17 papers receiving 505 citations

Peers

Countries citing papers authored by Gianmario Candore

Since Specialization

Citations

This map shows the geographic impact of Gianmario Candore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianmario Candore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianmario Candore more than expected).

Fields of papers citing papers by Gianmario Candore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianmario Candore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianmario Candore. The network helps show where Gianmario Candore may publish in the future.

Co-authorship network of co-authors of Gianmario Candore

This figure shows the co-authorship network connecting the top 25 collaborators of Gianmario Candore. A scholar is included among the top collaborators of Gianmario Candore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianmario Candore. Gianmario Candore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Title	Journal	Authors	Indexed citations
1	FRAME: Framework for Real‐World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness – An Evaluation of Regulatory and Health Technology Assessment Decision Making	Clinical Pharmacology & Therapeutics	Gianmario Candore, Claire Martin et al.	1
2	Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance	Drug Safety	Andrew Bate, Jackie Brown et al.	3
3	Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination	Drug Safety	María Gordillo‐Marañón, Gianmario Candore et al.	5
4	Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice	British Journal of Clinical Pharmacology	Jim Slattery, Chantal Quinten et al.	5
5	The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions	Drug Safety	Gianmario Candore, Jim Slattery et al.	10
6	Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users	Drug Safety	Karin Hedenmalm, Alexandra Păcurariu et al.	5
7	Different Strategies to Execute Multi‐Database Studies for Medicines Surveillance in Real‐World Setting: A Reflection on the European Model	Clinical Pharmacology & Therapeutics	Rosa Gini, Miriam Sturkenboom et al.	36
8	Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?	Clinical Pharmacology & Therapeutics	Gianmario Candore, Karin Hedenmalm et al.	7
9	A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children	Pharmacoepidemiology and Drug Safety	Karin Hedenmalm, Kevin Blake et al.	14
10	EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection	Drug Safety	Jim Slattery, Jean‐Michel Dogné et al.	90
11	Patient Reporting in the EU: Analysis of EudraVigilance Data	Drug Safety	Gianmario Candore, Jim Slattery et al.	59
12	An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance	Pharmacoepidemiology and Drug Safety	Gianmario Candore, Jim Slattery et al.	8
13	Good Signal Detection Practices: Evidence from IMI PROTECT	Drug Safety	A Wisniewski, Andrew Bate et al.	106
14	Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases	Drug Safety	Suzie Seabroke, Gianmario Candore et al.	43
15	Case‐only designs for studying the association of antidepressants and hip or femur fracture	Pharmacoepidemiology and Drug Safety	Mark de Groot, Gianmario Candore et al.	11
16	Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fracture	Pharmacoepidemiology and Drug Safety	Md Jamal Uddin, Rolf H. H. Groenwold et al.	6
17	Comparison of Statistical Signal Detection Methods Within and Across Spontaneous Reporting Databases	Drug Safety	Gianmario Candore, Kristina Juhlin et al.	106
18	Impact of Subgroup Analyses and Adjustment by Stratification on Safety Signal Detection for Individual Case Reports	Pharmacoepidemiology and Drug Safety	Suzie Seabroke, Kristina Juhlin et al.	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact